Femasys shares surge 16.53% after-hours after announcing Swiss distribution partnership with OR Consulting for European expansion.

Femasys Inc. surged 16.53% in after-hours trading following the announcement of a strategic distribution partnership with OR Consulting to launch its product portfolio in Switzerland. The agreement, which includes FemBloc Permanent Birth Control, FemaSeed Intratubal Insemination, and other fertility and diagnostic products, marks continued progress in the company’s European expansion strategy, building on recent market entries in Spain and France. The partnership underscores Femasys’ focus on broadening access to its innovative women’s health technologies through experienced regional partners, with Switzerland providing entry to its full portfolio. CEO Kathy Lee-Sepsick highlighted the partnership as a reflection of the company’s disciplined approach to multi-country growth, while OR Consulting emphasized Switzerland’s significance as a sophisticated market for women’s health innovation. The news aligns with Femasys’ ongoing commercial momentum in Europe and its long-term global expansion goals.